Edition:
United Kingdom

Orion Oyj (ORNAV.HE)

ORNAV.HE on Helsinki Stock Exchange

31.45EUR
18 Sep 2018
Change (% chg)

€0.55 (+1.78%)
Prev Close
€30.90
Open
€30.85
Day's High
€31.50
Day's Low
€30.65
Volume
5,671
Avg. Vol
7,076
52-wk High
€40.39
52-wk Low
€24.75

Chart for

About

Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical... (more)

Overall

Beta: 0.69
Market Cap(Mil.): €5,443.56
Shares Outstanding(Mil.): 141.26
Dividend: 1.35
Yield (%): 4.02

Financials

  ORNAV.HE Industry Sector
P/E (TTM): 21.94 30.93 32.76
EPS (TTM): 1.76 -- --
ROI: 33.35 15.07 14.61
ROE: 46.01 16.59 16.33

BRIEF-Orion Oyj to sell its Orion Diagnostica division

* REG-ORION TO SELL ITS ORION DIAGNOSTICA DIVISION - DUE TO THE TRANSACTION ORION UPDATES ITS OUTLOOK

20 Apr 2018

BRIEF-Orion Updates Primary Completion Date Of Phase III To September 2018

* STATUS UPDATE OF THE PHASE III ARAMIS CLINICAL TRIAL WITH DAROLUTAMIDE IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

03 Apr 2018

Earnings vs. Estimates